Novo Nordisk partners with Anthropic to accelerate drug development

Novo Nordisk A/S and Anthropic announced on September 16, 2026 a partnership to use artificial intelligence, specifically Claude, to speed drug development. The collaboration aims to help Novo compete in the obesity treatment market.

2 reportstech · international

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage